Adherence to desferrioxamine and deferiprone and the impact of deferiprone co-prescription in thalassaemia major patients. Does the addition of deferiprone improve adherence?
Giselle
G
Kidson-Gerber
Robert
R
Lindeman
D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D010349:Patient Compliance; D011728:Pyridones / Q000627:therapeutic use*; D017262:Siderophores / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000188:drug therapy*
D007502:Iron Chelating Agents; D011728:Pyridones; D017262:Siderophores; D000077543:Deferiprone; D003676:Deferoxamine